These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 3864935)
1. Genetics and epidemiology of ataxia-telangiectasia. Swift M Kroc Found Ser; 1985; 19():133-46. PubMed ID: 3864935 [TBL] [Abstract][Full Text] [Related]
2. Incidence of cancer in 161 families affected by ataxia-telangiectasia. Swift M; Morrell D; Massey RB; Chase CL N Engl J Med; 1991 Dec; 325(26):1831-6. PubMed ID: 1961222 [TBL] [Abstract][Full Text] [Related]
3. Breast and other cancers in families with ataxia-telangiectasia. Swift M; Reitnauer PJ; Morrell D; Chase CL N Engl J Med; 1987 May; 316(21):1289-94. PubMed ID: 3574400 [TBL] [Abstract][Full Text] [Related]
4. Malignant neoplasms in the families of patients with ataxia-telangiectasia. Swift M; Sholman L; Perry M; Chase C Cancer Res; 1976 Jan; 36(1):209-15. PubMed ID: 1248000 [TBL] [Abstract][Full Text] [Related]
5. Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene. Swift M; Lukin JL Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3188-92. PubMed ID: 18990761 [TBL] [Abstract][Full Text] [Related]
6. [Ataxia telangiectasia: what impact in clinical oncology?]. Stoppa-Lyonnet D; Aurias A Bull Cancer; 1992; 79(7):645-50. PubMed ID: 1467590 [TBL] [Abstract][Full Text] [Related]
7. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Pippard EC; Hall AJ; Barker DJ; Bridges BA Cancer Res; 1988 May; 48(10):2929-32. PubMed ID: 3359449 [TBL] [Abstract][Full Text] [Related]
8. Cancer and autoimmune disease in families with common variable immune deficiency. Morrell D; Chase CL; Swift M Genet Epidemiol; 1986; 3(1):17-26. PubMed ID: 3957001 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Janin N; Andrieu N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D Br J Cancer; 1999 Jun; 80(7):1042-5. PubMed ID: 10362113 [TBL] [Abstract][Full Text] [Related]
10. Cellular hypersensitivity to chronic gamma-radiation in cultured fibroblasts from ataxia-telangiectasia heterozygotes. Paterson MC; MacFarlane SJ; Gentner NE; Smith BP Kroc Found Ser; 1985; 19():73-87. PubMed ID: 3864940 [TBL] [Abstract][Full Text] [Related]
11. Genetic aspects of ataxia-telangiectasia. Swift M Immunodefic Rev; 1990; 2(1):67-81. PubMed ID: 2196911 [TBL] [Abstract][Full Text] [Related]
12. Malignant disease in heterozygous carriers. Swift M Birth Defects Orig Artic Ser; 1976; 12(1):133-44. PubMed ID: 990439 [No Abstract] [Full Text] [Related]
13. Identification of ataxia telangiectasia heterozygotes, a cancer-prone population, using the single-cell gel electrophoresis (Comet) assay. Djuzenova CS; Schindler D; Stopper H; Hoehn H; Flentje M; Oppitz U Lab Invest; 1999 Jun; 79(6):699-705. PubMed ID: 10378512 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
16. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Su Y; Swift M Ann Intern Med; 2000 Nov; 133(10):770-8. PubMed ID: 11085839 [TBL] [Abstract][Full Text] [Related]
17. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Hall EJ; Schiff PB; Hanks GE; Brenner DJ; Russo J; Chen J; Sawant SG; Pandita TK Cancer J Sci Am; 1998; 4(6):385-9. PubMed ID: 9853138 [TBL] [Abstract][Full Text] [Related]